EX-10.1 2 ex10-1.htm DISTRIBUTION AND COMMERCIALIZATION AGREEMENT Adamis Pharmaceuticals, Corporation 10-Q Exhibit [10.1] Execution Version [*] Designates Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential...Distribution and Commercialization Agreement • May 5th, 2020 • New York
This Distribution and Commercialization Agreement (the “Agreement”) is made effective as of the Effective Date by and between Adamis Pharmaceuticals Corporation, a corporation organized under the laws of Delaware (the “Company”), with an office located at 11682 El Camino Real, Suite #300, San Diego, CA 92130 and Sandoz Inc., a corporation organized under the laws of Colorado, with an office at 100 College Road West, Princeton, New Jersey 08540 (“Sandoz”). Sandoz and the Company may hereafter be referred to collectively as the “Parties” and individually as a “Party”.
DISTRIBUTION AND COMMERCIALIZATION AGREEMENTDistribution and Commercialization Agreement • November 7th, 2014 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS DISTRIBUTION AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is entered into as of July 18, 2014 (the “Effective Date”) by and between ANACOR PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 1020 East Meadow Circle, Palo Alto, CA 94303 (“Anacor”) and SANDOZ INC., a Colorado corporation having its principal place of business at 506 Carnegie Center, Suite 400, Princeton, NJ 08540 (“Sandoz”). Anacor and Sandoz are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. Such omitted information is indicated by brackets (“[…***…]” in...Distribution and Commercialization Agreement • August 17th, 2020 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
This Distribution and Commercialization Agreement (the “Agreement”) is made effective as of the Effective Date (as defined herein) by and between Adamis Pharmaceuticals Corporation, a corporation organized under the laws of Delaware, with an office located at 11682 El Camino Real, Suite #300, San Diego, California 92130 (“Company”) and USWM, LLC, a limited liability company organized under the laws of Delaware, with an office at [***] (“USWM”). Company and USWM may hereafter be referred to collectively as the “Parties” and individually as a “Party”.
